{
    "nctId": "NCT02561468",
    "briefTitle": "The Preemptive Analgesic Efficacy of Nefopam",
    "officialTitle": "N/A",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Neoplasm",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 94,
    "primaryOutcomeMeasure": "The change of pain numerical rating score from postoperative 30 min until postoperative 3 month",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients diagnosed with breast cancer\n* Lumpectomy with axillary lymph node dissection or Lumpectomy with sentinel lymph node biopsy\n* American Society of Anesthesiologists physical status I or II\n\nExclusion Criteria:\n\n* Refusal\n* Seizure\n* Cardiac disease\n* Monoamine oxidase inhibitor user\n* Urologic disease\n* Glucoma\n* Preoperative analgesic drug medication\n* Pregnancy\n* Recurred breast cancer patient",
    "sex": "FEMALE",
    "minimumAge": "20 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}